JP2004512301A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004512301A5 JP2004512301A5 JP2002537303A JP2002537303A JP2004512301A5 JP 2004512301 A5 JP2004512301 A5 JP 2004512301A5 JP 2002537303 A JP2002537303 A JP 2002537303A JP 2002537303 A JP2002537303 A JP 2002537303A JP 2004512301 A5 JP2004512301 A5 JP 2004512301A5
- Authority
- JP
- Japan
- Prior art keywords
- pcp
- addiction
- gvg
- mammal
- related behavior
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010012335 Dependence Diseases 0.000 description 4
- PJDFLNIOAUIZSL-UHFFFAOYSA-N vigabatrin Chemical compound C=CC(N)CCC(O)=O PJDFLNIOAUIZSL-UHFFFAOYSA-N 0.000 description 4
- 241000124008 Mammalia Species 0.000 description 3
- 230000000694 effects Effects 0.000 description 2
- 235000019788 craving Nutrition 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000007659 motor function Effects 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/694,040 US6395783B1 (en) | 2000-10-23 | 2000-10-23 | Treatment of PCP addiction and PCP addiction-related behavior |
| PCT/US2001/007233 WO2002034249A1 (en) | 2000-10-23 | 2001-03-07 | Treatment of pcp addiction and pcp addiction-related behavior |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004512301A JP2004512301A (ja) | 2004-04-22 |
| JP2004512301A5 true JP2004512301A5 (enExample) | 2008-04-24 |
Family
ID=24787164
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002537303A Pending JP2004512301A (ja) | 2000-10-23 | 2001-03-07 | Ｐｃｐ中毒及びｐｃｐ中毒に関連する行動の治療法 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6395783B1 (enExample) |
| EP (1) | EP1335717A4 (enExample) |
| JP (1) | JP2004512301A (enExample) |
| KR (1) | KR20030074610A (enExample) |
| CN (2) | CN1771929A (enExample) |
| AU (2) | AU4201101A (enExample) |
| BR (1) | BR0114898A (enExample) |
| CA (1) | CA2426210C (enExample) |
| CZ (1) | CZ20031431A3 (enExample) |
| HR (1) | HRP20030322A2 (enExample) |
| HU (1) | HUP0301441A3 (enExample) |
| IL (2) | IL155574A0 (enExample) |
| MX (1) | MXPA03003589A (enExample) |
| NO (1) | NO20031814L (enExample) |
| NZ (1) | NZ526072A (enExample) |
| PL (1) | PL361028A1 (enExample) |
| WO (1) | WO2002034249A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
| US9101545B2 (en) | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
| CN114903006B (zh) * | 2021-02-09 | 2024-08-02 | 中国科学院脑科学与智能技术卓越创新中心 | 一种非人灵长类动物物质成瘾模型的构建方法与应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2133002B (en) | 1982-12-30 | 1986-01-29 | Merrell Toraude & Co | Process for preparing 4-amino-5-hexenoic acid |
| GB8311804D0 (en) | 1983-04-29 | 1983-06-02 | Merrell Toraude & Co | Treatment of seizure disorders and pharmaceutical compositions |
| US4595697A (en) | 1984-03-28 | 1986-06-17 | Merrell Dow Pharmaceuticals Inc. | Treatment of seizure disorders and pharmaceutical compositions useful therein |
| US5189064A (en) | 1985-07-22 | 1993-02-23 | Matrix Technologies, Inc. | Treatment of cocaine addiction |
| EP0381696B1 (en) | 1987-10-07 | 1993-07-28 | Matrix Technologies, Inc. | Pharmaceutical composition for the treatment of cocaine addiction |
| US5102913A (en) * | 1991-07-01 | 1992-04-07 | Halikas James A | Treatment for cocaine use employing valproic acid |
| HUP0100115A2 (hu) | 1997-10-28 | 2001-06-28 | Schering Corp. | Eljárás kóros vágy csökkentésére emlősökben |
| US6541520B1 (en) * | 1998-08-05 | 2003-04-01 | Brookhaven Science Associates | Treatment of addiction and addiction-related behavior |
| ES2238999T3 (es) | 1999-02-24 | 2005-09-16 | University Of Cincinnati | Uso de derivados de sulfamato para tratar trastornos en el control de los impulsos. |
-
2000
- 2000-10-23 US US09/694,040 patent/US6395783B1/en not_active Expired - Fee Related
-
2001
- 2001-03-01 AU AU4201101A patent/AU4201101A/xx active Pending
- 2001-03-07 CZ CZ20031431A patent/CZ20031431A3/cs unknown
- 2001-03-07 EP EP01913336A patent/EP1335717A4/en not_active Ceased
- 2001-03-07 KR KR10-2003-7005616A patent/KR20030074610A/ko not_active Ceased
- 2001-03-07 CA CA002426210A patent/CA2426210C/en not_active Expired - Fee Related
- 2001-03-07 IL IL15557401A patent/IL155574A0/xx unknown
- 2001-03-07 CN CNA2005101232670A patent/CN1771929A/zh active Pending
- 2001-03-07 NZ NZ526072A patent/NZ526072A/en unknown
- 2001-03-07 HU HU0301441A patent/HUP0301441A3/hu unknown
- 2001-03-07 JP JP2002537303A patent/JP2004512301A/ja active Pending
- 2001-03-07 WO PCT/US2001/007233 patent/WO2002034249A1/en not_active Ceased
- 2001-03-07 BR BR0114898-2A patent/BR0114898A/pt not_active Application Discontinuation
- 2001-03-07 HR HR20030322A patent/HRP20030322A2/hr not_active Application Discontinuation
- 2001-03-07 MX MXPA03003589A patent/MXPA03003589A/es active IP Right Grant
- 2001-03-07 AU AU2001242011A patent/AU2001242011B8/en not_active Ceased
- 2001-03-07 PL PL01361028A patent/PL361028A1/xx not_active Application Discontinuation
- 2001-03-07 CN CNB018192289A patent/CN1234352C/zh not_active Expired - Fee Related
-
2003
- 2003-04-23 NO NO20031814A patent/NO20031814L/no not_active Application Discontinuation
- 2003-04-24 IL IL155574A patent/IL155574A/en not_active IP Right Cessation